Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.06%
+14.86%
-3.80%
-3.18%
-0.44%
CRM
Salesforce
$263.41
Strengths
Earnings are forecast to grow
Trading below its fair value
Upgraded on attractively valued
Outperform the market
Technical Indicators
Aroon crosses up
Chart
$245.89 (+7.13%)
$267.39 (-1.49%)
$265.37 (-0.74%)
$298.01 (-11.61%)
CRM has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Investors losing confidence
Hit 52-week low
CRM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Eps growth
Earnings increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
CRM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRM Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
CRM Earnings
The TTM reflects 12-month period, providing review of CRM financial performance.
The company financial health has moderately improved over the past year
Financial Score
CRWD
503.95
+0.07%
HUBS
478.01
+5.85%
PLTR
181.51
-0.04%
INFA
24.85
0.00%
MSFT
517.66
+0.17%
What is CRM current stock price?
What are CRM stock strengths?
What risks are associated with CRM stock?
When is CRM next earnings report?
What is CRM market cap and volume?
What is CRM's current Stock IQ?
Should I buy CRM stock right now?
Is CRM a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRM?
What does a 'Strong Sell' rating mean for CRM?
What factors influence CRM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.06%
+14.86%
-3.80%
-3.18%
-0.44%
CRM
Salesforce
Current Price
$263.41
Stock Insights
Strengths
Earnings are forecast to grow
Trading below its fair value
Upgraded on attractively valued
Outperform the market
Technical Indicators
Aroon crosses up
Linked to CRM
CRWD
503.95
+0.07%
HUBS
478.01
+5.85%
PLTR
181.51
-0.04%
INFA
24.85
0.00%
MSFT
517.66
+0.17%
Chart
$245.89 (+7.13%)
$267.39 (-1.49%)
$265.37 (-0.74%)
$298.01 (-11.61%)
CRM Analysts Opinion
CRM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Eps growth
Earnings increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
CRM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRM Street view is extremely bullish and have positive views on the near-term outlook
CRM has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Investors losing confidence
Hit 52-week low
Average key support and resistance price levels.
CRM Earnings
The TTM data reflects the most recent 12-month period, providing overview of CRM financial performance.
CRM Financial Health
The company financial health has moderately improved over the past year
Financial Score
CRM Latest Analysis
Coupa Announces Coupa Contracts for Agentforce on Salesforce AppExchange. Coupa customers can now benefit from streamlined contract creation within the Salesforce platform Coupa is currently available on AppExchange .Coupa Contracts for AgentforceBy utilizing this Agentforce ...
Today
SunPower Announces Record Profit in Q325. the Company or Nasdaq: SPWR a solar technology services and installation company will present its Q3'.25 results via webcast today Tuesday October 21 at 1:00pm ET. Interested parties may access the webcast by registering or by visiting the Events page within the IR section of the company website: .The preliminary Q3'.25 quarterly report of key financial parameters is shown below. The final Q3'.25 quarterly report will be the SEC 10Q report
Today
CRM Quantitative Stock Analysis. Below is Valideas guru fundamental report for SALESFORCE INC (CRM). Of the 22 guru strategies we follow CRM rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a
Today
Google Salesforce Expand Partnership Integrating Gemini AI into Agentforce 360 Platform.
Today
Salesforce leads enterprise software stocks higher as market climbs.
Mon Oct 20, 2025
Salesforce: Extreme Bargain In Plain Sight.
Fri Oct 17, 2025
Salesforce.com (CRM) Soars 4.0%: Is Further Upside Left in the Stock?. Salesforce.com (CRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Fri Oct 17, 2025
Macquarie Maintains Salesforce (CRM) Neutral Recommendation. Fintel reports that on October 16 2025 Macquarie maintained coverage of Salesforce (NYSE:CRM) with a Neutral recommendation. Analyst Price Forecast Suggests 39.08% Upside
Fri Oct 17, 2025
DA Davidson Maintains Salesforce (CRM) Neutral Recommendation. Fintel reports that on October 16 2025 DA Davidson maintained coverage of Salesforce (NYSE:CRM) with a Neutral recommendation. Analyst Price Forecast Suggests 39.08% Upside
Fri Oct 17, 2025
Wedbush Reiterates Salesforce (CRM) Outperform Recommendation. Fintel reports that on October 16 2025 Wedbush reiterated coverage of Salesforce (NYSE:CRM) with a Outperform recommendation. Analyst Price Forecast Suggests 39.08% Upside
Fri Oct 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.